Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-14

Clinical Trial Update: Pitolisant in Refractory Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for pitolisant in refractory restless legs syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pitolisant (pitolisant)

Snippet

Sponsor: William Ondo, MD | Conditions: Restless Legs Syndrome | Phase 4 | Status: UNKNOWN